Each 1g of Mirvaso Gel contains approximately:
3.3mg brimonidine, equivalent to 5mg brimonidine tartrate.
Other ingredients include:
Carbomer
Methyl parahydroxybenzoate (E218)
Phenoxyethanol
Glycerol
Titanium dioxide
Propylene glycol
Sodium hydroxide
Purified water
Contains methyl parahydroxybenzoate, which may cause allergic reactions, and propylene glycol, which may cause skin irritation.
Mirvaso 3mg/g Gel 30g (Brimonidine)
Dosage: Brimonidine 3mg/g Gel
Pack size: 30g
Manufacturer: Galderma (U.K.) Limited
Prescription required
Mirvaso 3mg/g Gel contains brimonidine, a prescription treatment used to reduce persistent facial redness caused by rosacea in adults.
Brimonidine works by temporarily narrowing small blood vessels in the facial skin, helping reduce excess blood flow and visible redness.
Mirvaso is applied once daily and is specifically intended to treat facial erythema associated with rosacea.
Active ingredient: Brimonidine
Pack size: 30g
Form: Gel
Medicine type: Prescription Only Medicine (POM)
Treatment is subject to an appropriate clinical assessment and prescription.
Each 1g of Mirvaso Gel contains approximately:
3.3mg brimonidine, equivalent to 5mg brimonidine tartrate.
Other ingredients include:
Carbomer
Methyl parahydroxybenzoate (E218)
Phenoxyethanol
Glycerol
Titanium dioxide
Propylene glycol
Sodium hydroxide
Purified water
Contains methyl parahydroxybenzoate, which may cause allergic reactions, and propylene glycol, which may cause skin irritation.
